Here’s How Your Returns Would Look if You Had Invested in Aphria (TSX:APHA) When Pot Was Legalized

Aphria Inc (TSX:APHA)(NYSE:APHA) got a big boost this month after posting a strong quarter, but would it have been a good investment to make when pot was legalized?

edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis has undoubtedly been the hottest industry over the past couple of years. We’ve seen some soaring valuations and companies trade at ridiculous multiples of their sales. Even significant cash burn and mounting losses haven’t been able to keep investors away.

Recently, however, we have seen more bearish activity in the industry and valuations have started to come down, but not nearly enough to wipe away the growth that some stocks have achieved.

Earlier this month, we saw Aphria Inc (TSX:APHA)(NYSE:APHA) jump in value after it posted a profit and got investors excited about the possibility of a marijuana company actually not being in the red.

After all, it’s not a sight that we’ve seen very often, as normally cannabis companies are mounting losses and that hasn’t always gone over very well, especially when it brings down the earnings of a big investor.

How Aphria has done this past year

Aphria typically hasn’t been one of the strongest performing cannabis stocks, normally lagging behind the industry leaders. If we ignore the recent bump up in price that the company got from its earnings result, then through the first seven months of the year,

Aphria’s share price has actually fallen by about 9%. The stock was doing well until about April when a disappointing quarter sent the stock over a cliff.

However, let’s take a look back even further, to when marijuana was legalized, on October 17, 2018. Here’s how your returns would have looked if you had invested on that day:

APHA Chart

It’s a dark reality of how bearish investors have been on pot stocks since then. No longer are promises of future growth and potential enough to get investors excited about cannabis.

Even with the legalization of edibles around the corner, it hasn’t been enough to give prices a boost. If we extend the returns to the end of last week and include the boost that Aphria received from earnings, it’s still nowhere near enough to make up for the losses since legalization:

APHA Chart

Takeaways for investors

There are a couple of important takeaways from this.

The first is that leading up into legalization we saw cannabis stocks soaring even though the bullishness may not have been warranted, making the shares significantly overpriced.

Many of those investors likely sold off their shares with legalization having come and gone, knowing full well that reality had arrived and that it was time for companies to start performing and measuring them against the sky-high growth many expected for the industry.

It was a tall task — one that investors likely knew wasn’t going to happen. It’s an important reminder that hype alone can’t make a stock a good investment.

Another important takeaway is that as quickly as pot stocks soared, they have crashed just as quickly. Most of the losses that Aphria incurred since October took place in just the first few months after legalization.

With cannabis stocks still looking pretty expensive today, there may be another wave of sell-offs still to come.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »